spr741
Small moleculeexperimental
Clinical trial activity
2 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Dec 1, 2016 (NCT03022175)
Timeline
2010s
- Jan 1, 2016
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- spr741
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03376529 | Phase 1 | Nov 10, 2017 | QPS, Simbec-Orion, Spero Therapeutics |
| NCT03022175 | Phase 1 | Dec 1, 2016 | CPR Pharma Services Pty Ltd, Australia, IDT Australia Ltd., Spero Therapeutics |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Spero Therapeutics | For profit | 2 | 2 | 1 | 2016 |
| CPR Pharma Services Pty Ltd, Australia | For profit | 1 | 0 | 1 | 2016 |
| IDT Australia Ltd. | For profit | 1 | 0 | 1 | 2016 |
| QPS | For profit | 1 | 0 | 1 | 2017 |
| Simbec-Orion | For profit | 1 | 0 | 1 | 2017 |
5 organizations
Page 1 / 1